71610-802-60 (71610 802 60)
Amlodipine Besylate Tablet
Product Images NDC 71610-802
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Figure-1 (Figure1)
This is a description of Event Rate analysis for a study involving Amlodipine and Placebo. The hazard ratio is 0.691 with a 95% confidence interval of (0.54, 0.88) and a P-value of 0.003. The timeline spans from 0 to 24 months with the number of participants at risk decreasing over time.*
Figure-2 (Figure2)
This text appears to be a summary of patient demographics and characteristics related to a study or clinical trial. It includes information such as the number of patients in different age groups, gender distribution, baseline sitting SBP, presence of vessel disease and stenosis, PCl-stent strata, and comparison between Amlodipine and Placebo. The text also mentions hazard ratio and confidence intervals. It seems to provide data on how different factors are distributed among a total of 1318 patients.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
